Research Insight
Research Insight
UCLA surgeons find new way to shield vision during radiation for eye cancer
Eye cancer patients face an unenviable dilemma. They must enter treatment knowing that their surgeon's strategy to kill the deadly tumor with radiation may also sacrifice their eyesight. Now, UCLA researchers have discovered that a...
Research Insight
Researchers create tumor-fighting immune cells, watch in real time as they kill cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well-armed battalion of tumor-seeking immune system cells and used positron emission tomography (PET) to watch in real time as these special forces traveled throughout the body to locate...
Research Insight
Researchers use nanoparticles to shrink tumors in mice
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells...
Research Insight
MRI study could prove useful in early detection of Alzheimer’s disease
Scientists at the University of Kentucky's College of Medicine have identified changes in the brains of normal individuals at high risk for Alzheimer's disease that could prove important for early detection of the disease. The research,...
Research Insight
‘Beeglue’ may help deliver new treatments for fatal infections
Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug, according to research led at the University of Strathclyde in Glasgow, Scotland. The scientists found that a substance...
Research Insight
Transposons create genomic instability and are implicated in cancer and other diseases
Transposons, or "jumping genes," make up roughly half of the human genome. Geneticists previously estimated that they replicate and insert themselves into new locations roughly one in every 20 live births. New results, published in the...
Research Insight
Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers
Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read